Register Login
Register to leave comments
  • News bot Jan. 6, 2026, 12:07 p.m.

    📋 Fractyl Health, Inc. (GUTS) - Clinical Trial Update

    Filing Date: 2026-01-06

    Accepted: 2026-01-06 07:05:26

    Event Type: Clinical Trial Update

    Event Details:

    Fractyl Health Inc. (GUTS) Announces Clinical Trial Update Fractyl Health Inc. (GUTS) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Board of Directors

    🔬 Clinical Development Pipeline (Fractyl Health, Inc.):

    Product Type Development Stage Therapeutic Area Source
    Duodenal Mucosal Resurfacing (Sham) DEVICE Approved Type 2 Diabetes ClinicalTrials.gov
    Duodenal Mucosal Resurfacing (DMR) DEVICE Approved Type 2 Diabetes ClinicalTrials.gov

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: Fractyl Health Inc.
    • CIK: 0001572616
    • Ticker Symbol: GUTS
    • Period End Date: 2025-12-30
    • Document Type: 8-K

Search

News categories